Ledger.Open graph →
SEC Form D · filed February 28, 2025

Maxymune Therapeutics, Inc

Offering
$2.5M
Sold
$850K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ALTOS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Tatjana Naranda · Los Altos, CAExecNeil Solomons · Victoria, British Columbia, CanadaDirectorGordon Ringold · Palo Alto, CAExec · DirectorTatjana Naranda · Los Altos, CAExecNeil Solomons · Victoria, British Columbia, CanadaDirectorGordon Ringold · San Carlos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗